勘误：用于解析髓系肿瘤免疫微环境的单细胞技术：观点与机遇
Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities.
作者信息
Caprioli Chiara, Nazari Iman, Milovanovic Sara, Pelicci Pier Giuseppe
机构信息
Department of Experimental Oncology, IRCCS Istituto Europeo di Oncologia, Milan, Italy.
Scuola Europea di Medicina Molecolare (SEMM) European School of Molecular Medicine, Milan, Italy.
出版信息
Front Oncol. 2022 Aug 15;12:974476. doi: 10.3389/fonc.2022.974476. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fonc.2021.796477.].
摘要
[本文更正了文章DOI：10.3389/fonc.2021.796477。]
相似文献
1
Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities.勘误：用于解析髓系肿瘤免疫微环境的单细胞技术：观点与机遇
Front Oncol. 2022 Aug 15;12:974476. doi: 10.3389/fonc.2022.974476. eCollection 2022.
2
Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities.解析髓系肿瘤免疫微环境的单细胞技术：前景与机遇
Front Oncol. 2022 Feb 2;11:796477. doi: 10.3389/fonc.2021.796477. eCollection 2021.
3
How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?克隆性造血的发现对于骨髓增生异常综合征（MDS）或急性髓系白血病（AML）的发展有多大的预测性？
Best Pract Res Clin Haematol. 2021 Dec;34(4):101327. doi: 10.1016/j.beha.2021.101327. Epub 2021 Oct 23.
4
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells.勘误：作为苦味受体激动剂的苯甲地那铵可改变急性髓系白血病细胞的转录组特征和功能。
Front Oncol. 2021 Apr 8;11:668460. doi: 10.3389/fonc.2021.668460. eCollection 2021.
5
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.转化生长因子 β1 介导的骨髓增生异常综合征和急性髓系白血病间充质基质细胞功能抑制。
Haematologica. 2018 Sep;103(9):1462-1471. doi: 10.3324/haematol.2017.186734. Epub 2018 May 17.
6
Corrigendum: C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma.勘误：C反应蛋白是肝细胞癌中髓样细胞所营造的免疫抑制微环境的一个指标。
Front Oncol. 2023 Oct 24;13:1280727. doi: 10.3389/fonc.2023.1280727. eCollection 2023.
7
Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.免疫失调与骨髓增生异常综合征发病机制中的反复突变。
Adv Exp Med Biol. 2021;1326:1-10. doi: 10.1007/5584_2020_608.
8
Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia.骨髓增生异常综合征和急性髓系白血病中驱动免疫逃逸的微环境特征
Diseases. 2022 Jun 10;10(2):33. doi: 10.3390/diseases10020033.
9
[Clonal evolution of myelodysplastic syndromes].[骨髓增生异常综合征的克隆进化]
Rinsho Ketsueki. 2020;61(4):358-367. doi: 10.11406/rinketsu.61.358.
10
Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia.勘误：急性髓系白血病中Stellae - 123预后基因表达特征的评估。
Front Oncol. 2023 Oct 4;13:1302993. doi: 10.3389/fonc.2023.1302993. eCollection 2023.
引用本文的文献
1
NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study.下一代测序panel 增强 WHO-HAEM5 和国际共识分类下髓系肿瘤的精确诊断：一项观察性研究。
Medicine (Baltimore). 2024 Jun 14;103(24):e38556. doi: 10.1097/MD.0000000000038556.
Zotero 插件